Beraprost sodium improves survival rates in anti-glomerular basement membrane glomerulonephritis and 5/6 nephrectomized chronic kidney disease rats

K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification

Andrew S. Levey, Josef Coresh, Kline Bolton et al. · Data Archiving and Networked Services (DANS) · 2002 · 11.7K citations

Medicine, Nephrology, Hemodialysis +13

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Barry M. Brenner, Mark E. Cooper, Dick de Zeeuw et al. · New England Journal of Medicine · 2001 · 7.5K citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Renoprotective Effect of the Angiotensin-Receptor Antagonist Irbesartan in Patients with Nephropathy Due to Type 2 Diabetes

Edmund J. Lewis, Lawrence G. Hunsicker, William R. Clarke et al. · New England Journal of Medicine · 2001 · 6K citations · Full text

Medicine, Nephrology, Pharmacology +16

Effect of Blood Pressure Lowering and Antihypertensive Drug Class on Progression of Hypertensive Kidney Disease<SUBTITLE>Results From the AASK Trial</SUBTITLE>

Jackson T. Wright · JAMA · 2002 · 2K citations

Medicine, Nephrology, Pharmacotherapy +14

Serum Indoxyl Sulfate Is Associated with Vascular Disease and Mortality in Chronic Kidney Disease Patients

Fellype Carvalho Barreto, Daniela Veit Barreto, Sophie Liabeuf et al. · Clinical Journal of the American Society of Nephrology · 2009 · 905 citations · Full text

Medicine, Biochemistry, Nephrology +15